Skip to main content
Phase 3 topline results ‘disappointing’ for novel antidepressant as monotherapy
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Phase 3 topline results ‘disappointing’ for novel antidepressant as monotherapy
User login
Username
Password
Reset your password
Concept
Lead
score
Depression
1
1
Antidepressant drug
0
0.78
Calcaneal
0
0.26
Experimental Drug
0
0.26
Hospital
0
0.26
Major Depression
0
0.26
Massachusetts
0
0.26
Receptors
0
0.26
Specialty
Lead
score
Psychiatry
1
1
Family Medicine/Primary Care
0
1
Internal Medicine
0
1
Pharmacist
0
1
Hospital Medicine
0
0.16
Edit Tags